Novartis Investigative Site

Springfield, Oregon 97477

We've found

3 trials

at this facility

Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies

Status: Enrolling, Phase
Updated: 12/31/1969

from

Springfield, OR

Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Springfield, OR

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Springfield, OR

Use our guide to learn which trials are right for you!